PHASE 1 STUDY OF JNJ‐67856633, A FIRST‐IN‐HUMAN MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Hertzberg, M., Kalac, M., Cheah, C. Y., Ribrag, V., Abrisqueta, P., Opat, S., Bachy, E., Ysebaert, L., Qiu, L., Yi, S., Nishimura, N., Lemech, C., Bussolari, J., Deng, C., Lu, T., Xiu, L., Hemelryck, S. V., Philippar, U., Guo, Y., Soete, V., Paradinas, I. S., Fourneau, N., Gerecitano, J., Morschhauser, F.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
P1195: A REAL WORLD EXPERIENCE OF COMBINED TREATMENT WITH ROMIDEPSIN AND AZACITIDINE IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA
Kalac, M., Tam, C., Goldfinger, M., Xiao, Z., Rajeeve, S., Montanari, F., Kanakry, J., O'Connor, O., Marchi, E.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
1638P Enzalutamide (enza) with or without leuprolide in patients (pts) with high-risk biochemically recurrent (hrBCR) prostate cancer (PC): EMBARK post hoc analysis by age
Shore, N.D., De Giorgi, U., Gleave, M.E., Kalac, M., Tang, Y., Croitoru, R., Rosales, M., Huynh, M., Tammela, T., Jan de Jong, I., Evans, C., Carcano, F.M., Freedland, S.J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1637P Efficacy of talazoparib and enzalutamide in mCRPC patients previously treated with androgen receptor pathway inhibitors (ARPI) or docetaxel: Post hoc analysis from both cohorts in TALAPRO-2 study
Agarwal, N., Azad, A.A., Galceran, J.C., Fay, A.P., Matsubara, N., Szczylik, C., De Giorgi, U., Joung, J.Y., Fong, P.C., Voog, E., Jones, R.J., Shore, N.D., Dunshee, C., Zschäbitz, S., Oldenburg, J., Lin, X., Laird, D., Kalac, M., Kennedy, D., Fizazi, K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1626P Incidence of hematologic toxicities in the homologous recombination repair (HRR)-deficient population of the TALAPRO-2 trial and their potential association with germline vs somatic origin of HRR gene alterations
Azad, A.A., Agarwal, N., Shore, N.D., Galceran, J.C., Fay, A.P., Matsubara, N., Saad, F., De Giorgi, U., Joung, J.Y., Fong, P.C., Zschäbitz, S., Piulats Rodriguez, J.M., Yip, S.M., Liu, G., DeAnnuntis, L., Lin, X., Laird, D., Kalac, M., Fizazi, K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
A Rare Tumor of the Diaphragm: Pleomorphic Rhabdomyosarcoma
Deniz, Pelin Pinar, MD, Kalac, Nilgun, MD, Ucoluk, Gulnur Onde, MD, Samurkasoglu, Belgin, MD, Tastepe, Abdullah Irfan, MD, Gulhan, Erkmen, MD, Demirag, Funda, MD
Published in The Annals of thoracic surgery (01.05.2008)
Published in The Annals of thoracic surgery (01.05.2008)
Get full text
Journal Article
New drugs for the treatment of lymphoma
Paoluzzi, Luca, Kitagawa, Yukiko, Kalac, Matko, Zain, Jasmine, O'Connor, Owen A
Published in Hematology/oncology clinics of North America (01.10.2008)
Published in Hematology/oncology clinics of North America (01.10.2008)
Get more information
Journal Article
Immediate-type hypersensitivity reactions due to antituberculosis drugs: a successful readministration protocol
Buhari, Gözde Köycü, MD, Keren, Metin, MD, Dursun, Adile Berna, MD, Güler, Müjgan, MD, Dulkar, Güngör, MD, Kalaç, Nilgün, MD, Özkara, Şeref, MD, Erkekol, Ferda Öner, MD
Published in Annals of allergy, asthma, & immunology (01.07.2015)
Published in Annals of allergy, asthma, & immunology (01.07.2015)
Get full text
Journal Article